AdvisorNet Financial, Inc - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 388 filers reported holding NEKTAR THERAPEUTICS in Q3 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
AdvisorNet Financial, Inc ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q2 2021$3,529,000
+3.9%
205,708
+21.2%
0.23%
-3.3%
Q1 2021$3,396,000
+2.9%
169,777
-12.5%
0.24%
-9.0%
Q4 2020$3,300,000
+31.1%
194,116
+27.9%
0.27%
+23.1%
Q3 2020$2,518,000
-36.2%
151,761
-10.9%
0.22%
-32.1%
Q2 2020$3,945,000
+29.3%
170,321
-0.3%
0.32%
+13.2%
Q1 2020$3,050,000
-0.6%
170,823
+20.2%
0.28%
+7.7%
Q4 2019$3,068,000
+342.1%
142,090
+272.6%
0.26%
+314.3%
Q3 2019$694,000
-76.4%
38,134
-53.8%
0.06%
-80.6%
Q2 2019$2,936,000
+17.7%
82,517
+11.2%
0.32%
+6.6%
Q1 2019$2,494,000
+23.3%
74,236
+20.6%
0.30%
+8.9%
Q4 2018$2,023,000
-48.6%
61,556
-4.7%
0.28%
-43.4%
Q3 2018$3,939,000
+236.1%
64,612
+169.3%
0.50%
+213.3%
Q2 2018$1,172,000
-59.5%
23,995
-11.9%
0.16%
-60.5%
Q1 2018$2,894,000
+944.8%
27,238
+487.7%
0.40%
+852.4%
Q4 2017$277,0004,6350.04%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2018
NameSharesValueWeighting ↓
TIRSCHWELL & LOEWY INC 588,908$7,138,0001.23%
Granahan Investment Management 3,693,956$44,771,0001.21%
NEA Management Company, LLC 1,825,600$22,126,0001.09%
FIC CAPITAL INC 150,868$1,829,0000.75%
Rhenman & Partners Asset Management AB 181,797$2,203,0000.66%
SOPHROSYNE CAPITAL LLC 60,200$728,0000.64%
HARVEY CAPITAL MANAGEMENT INC 130,400$1,580,0000.63%
Artal Group S.A. 1,300,000$15,756,0000.57%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 564,418$6,840,0000.47%
OppenheimerFunds, Inc. 24,400,000$295,728,0000.35%
View complete list of NEKTAR THERAPEUTICS shareholders